Figure 2.
Figure 2. Proportion of patients achieving LDH-N over time in the ravulizumab and eculizumab treatment groups. LDH-N is defined as proportion of patients who achieved LDH level ≤1× ULN (246 U/L).

Proportion of patients achieving LDH-N over time in the ravulizumab and eculizumab treatment groups. LDH-N is defined as proportion of patients who achieved LDH level ≤1× ULN (246 U/L).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal